Taro Pharmaceutical Industries Ltd.
TARO
TARO was delisted on the 21st of June, 2024.
89 hedge funds and large institutions have $771M invested in Taro Pharmaceutical Industries Ltd. in 2014 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 35 increasing their positions, 22 reducing their positions, and 15 closing their positions.
59% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 22
53% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 15
44% more funds holding in top 10
Funds holding in top 10: 9 → 13 (+4)
10% more capital invested
Capital invested by funds: $704M → $771M (+$67.4M)
9% more funds holding
Funds holding: 82 → 89 (+7)
88% less call options, than puts
Call options by funds: $1.13M | Put options by funds: $9.65M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Raging Capital Management
Rocky Hill,
New Jersey
|
+$20.4M |
| 2 |
Millennium Management
New York
|
+$14.7M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$13.9M |
| 4 |
GC
GW Capital
Bellevue,
Washington
|
+$13.3M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$9.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$47.9M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
-$44M |
| 3 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$9.34M |
| 4 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$7.65M |
| 5 |
WBC
Westpac Banking Corp
Sydney,
Australia
|
-$6.06M |
TARO Hedge Fund Activity: Q4 2014 in Review
89 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q4 2014, worth a combined $771M — up 9.6% from $704M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new TARO positions and 15 closed out — a net gain of 8 holders — while 35 added to existing stakes and 22 trimmed.
The largest buyer was Raging Capital Management, adding an estimated $20.4M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $47.9M sold.
- 89 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q4 2014, up from 82 in Q3 2014.
- Funds reported $771M of Taro Pharmaceutical Industries Ltd. stock for Q4 2014, up 9.6% quarter-over-quarter.
- 23 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q4 2014 and 15 closed out, a net change of +8 holders.
- The largest Taro Pharmaceutical Industries Ltd. buyer in Q4 2014 was Raging Capital Management, an estimated $20.4M added.
- The largest Taro Pharmaceutical Industries Ltd. seller in Q4 2014 was Consonance Capital Management, an estimated $47.9M sold.
Based on aggregated 13F filings for Q4 2014.